ISTA

Quote










































the word is that ista has plenty of investors with enough financial committments to buy the B&L pharma business. They lost out on inspire last year to merck but they still have the inverstors on board.
 


















Unfortunately BL sales force this is sounding more and more legit. ISTA was hotly persuing an antibiotic at Inspire but lost to Merck. They want to be in surgical full force. They need products and an antibiotic and steroid would fit the bill. Also, they tried to get Zirgan. Additionally, they do want the BL manufacturing facilities. BL reps do not realize that BL Tampa manufactures Bepreve for ISTA. Check the PI. Ista has a vested interest in acquiring both products and manufacturing facilities from BL. I think this is happening because ISTA is hungry and WP is desperate. Problem. ISTA has 200 reps now. They do not need anymore. Reps, managers and ancillary personnel are gone when this deal goes through.
 






Anonymous said:
Unfortunately BL sales force this is sounding more and more legit. ISTA was hotly persuing an antibiotic at Inspire but lost to Merck. They want to be in surgical full force. They need products and an antibiotic and steroid would fit the bill. Also, they tried to get Zirgan. Additionally, they do want the BL manufacturing facilities. BL reps do not realize that BL Tampa manufactures Bepreve for ISTA. Check the PI. Ista has a vested interest in acquiring both products and manufacturing facilities from BL. I think this is happening because ISTA is hungry and WP is desperate. Problem. ISTA has 200 reps now. They do not need anymore. Reps, managers and ancillary personnel are gone when this deal goes through.
Click to expand...

Supposedly, what is already obvious to us is also driving this. The management/research infrastructure at ISTA is much more "can do" in nature. WP would thus get a couple of board seats at ISTA once B&L pharma is folded in. The rest of us get shown the door.
 












as a current ISTA rep, this does really make sense. First of all, we barely lost out on inspire and our ceo does not like to lose and he won't likely do it again. B&L fits because the price is in our range 400-700 million. You have some decent products and, best of all, you have a generic manufacturing business.

We'll shut down the New Jersey business that Perry so stupidly put there. Keep the Tampa facilities and run everything out of So. Cal.
 






Anonymous said:
as a current ISTA rep, this does really make sense. First of all, we barely lost out on inspire and our ceo does not like to lose and he won't likely do it again. B&L fits because the price is in our range 400-700 million. You have some decent products and, best of all, you have a generic manufacturing business.

We'll shut down the New Jersey business that Perry so stupidly put there. Keep the Tampa facilities and run everything out of So. Cal.
Click to expand...

I'm sure they're letting reps in on executive decisions at ISTA even though you're right about Perry and all the flunkies that are worthless and suck us dry in the NJ offices.
 






B&L is toast and they'll keep telling you the company isn't for sale even while ReMax is hanging a For Lease sign on the Madison Office.

start looking for a job now. There will be no severance package worth any where near the financial value and job security of a new job in hand.
 






Anonymous said:
B&L is toast and they'll keep telling you the company isn't for sale even while ReMax is hanging a For Lease sign on the Madison Office.

start looking for a job now. There will be no severance package worth any where near the financial value and job security of a new job in hand.
Click to expand...

B and L isn't toast. B and L is stinky, burnt toast!
 












B&L's financials aren't worth the paper they're printed on. Company was in trouble with the NYSE multiple times because of bogus accounting on financials. If company released REAL financials it would show you that revenue has actually been increasing (because markets constantly expand), while market share has been declining across most brands, certainly pharma BU. All of this is for the North American Business units. I have no insight into the global BUs. As long as you don't lose market share points faster than the market grows you can still have positive revenue growth.

The most telling would be that cash flow and net margin has been rapidly declining because despite increased revenues the company is spending a fortune to lose share. and that my friends would mean NO ONE would buy the company. So you won't be seeing any financials out of B&L ever again.

Company will be sold for less than WP paid for it, because they are losing profitability every single day that they lose more market share. End of story.
 






Anonymous said:
B&L's financials aren't worth the paper they're printed on. Company was in trouble with the NYSE multiple times because of bogus accounting on financials. If company released REAL financials it would show you that revenue has actually been increasing (because markets constantly expand), while market share has been declining across most brands, certainly pharma BU. All of this is for the North American Business units. I have no insight into the global BUs. As long as you don't lose market share points faster than the market grows you can still have positive revenue growth.

The most telling would be that cash flow and net margin has been rapidly declining because despite increased revenues the company is spending a fortune to lose share. and that my friends would mean NO ONE would buy the company. So you won't be seeing any financials out of B&L ever again.

Company will be sold for less than WP paid for it, because they are losing profitability every single day that they lose more market share. End of story.
Click to expand...



When you see that WP actually wants to aquire assets not sell them, you'll be shocked!
 






Top Bottom
Back
Quote